Background: Currently, it is not possible to identify pregnant women at risk of sPTB due to bacterial infection. This study aimed to establish a vaginal bacterial DNA test for women in mid-pregnancy that would identify those at increased risk.
The placenta, a temporary organ that develops solely to support the growth of the fetus during gestation, is now recognised as a source of in utero microbial exposure. The impact of the in utero environment is well documented in developmental origins of health and disease. Microbial DNA, proteins and living cells reportedly result in both beneficial and adverse health events across the lifespan as a function of host-microbeenvironment interactions.
Methods: DNA was extracted from placental samples prior to 16s rRNA microbial community profiling using next-generation sequencing. Demographic data and clinical outcomes were collected for each mother-baby pair and correlated with microbial community profiles.
Results: The microbial community profile analysis revealed differences in the abundance and diversity of the microbial community members based on maternal and fetal compartments, fetal sex, and infant health outcomes.
Conclusions: The microbial community identified in multiple placental tissues demonstrates maternal-fetal compartmental differences and sexual dimorphism. The transient microbial community in this transitional organ has the potential to modulate fetal health outcomes as a function of host-microbe-environment interactions during the early developmental period. The placenta harbours a low biomass microbial community, the significance of which remains to be fully elucidated. Background: Hypoxic ischemic (HI) insults during pregnancy and birth can result in long term neurodevelopmental disorders, such as cerebral palsy. We have previously shown that human umbilical cord blood (hUCB) cells are effective at reducing neuroinflammation and improving brain injury in the short term. In this current study we aimed to examine the long-term outcomes and specifically the beneficial effect of repeated doses of hUCB and different administration routes. We hypothesised that multiple doses of hUCB would be more effective than a single dose.
REPEATED DOSES OF UMBILICAL CORD BLOOD CELLS MODULATE PERINATAL BRAIN INJURY
Methods: HI injury was induced in postnatal day (PND) 10 rats by left carotid artery ligation, followed by 90 min of hypoxia (8% oxygen). 24h later, pups were administered 1 million hUCB cells via intranasal or intraperitoneal route and received 1 dose (PND11), or 3 doses (PND11, 13, 20) . Rats were monitored until PND50; throughout this period, they underwent extensive behavioural testing. On PND50, brains were collected for immunohistological analysis.
Results: Following HI, there was a significant decrease in brain weight (P = 0.0115) and left hemisphere tissue area (P = 0.0015), and intranasal administration of multiple doses of hUCB cells significantly improved these (P = 0.0165 and 0.0395, respectively). In addition, there was a significant reduction in overall behavioural score following HI compared to sham (P=0.0076), this deficit was significantly ameliorated following treatment with multiple doses of hUCB, delivered intraperitoneally (P = 0.0442).
Conclusions: Treatment with repeated doses of hUCB cells is more effective than a single dose for reducing long-term tissue damage and restoring behavioural deficits following perinatal brain injury.
